A Study to Quantify Microvasculature Imaging for Breast Cancer Detection and Monitoring


About this study

The purpose of this study is to apply new microvasculature imaging for differentiation of breast lesions, and prediction of response to preoperative chemotherapy.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Aim 1:

  • Patient volunteers, ages ≥ 18 years.
  • Having suspicious breast masses scheduled for breast biopsy.
  • At least two weeks or more after breast biopsy.

Inclusion Criteria - Aim 2:

  • Patient volunteers, ages ≥ 18 years.
  • Suspicious breast masses scheduled for breast biopsy.
  • At least two weeks or more after breast biopsy.

Exclusion Criteria - Aims 1 and 2: 

  • Patients with breast implants, mastectomy or any condition that does not allow proper use of U.S.





Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Azra Alizad, M.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions